0001185185-21-000169.txt : 20210209 0001185185-21-000169.hdr.sgml : 20210209 20210209211544 ACCESSION NUMBER: 0001185185-21-000169 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210205 FILED AS OF DATE: 20210209 DATE AS OF CHANGE: 20210209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ODONNELL JEFFREY F CENTRAL INDEX KEY: 0001226425 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38659 FILM NUMBER: 21608857 MAIL ADDRESS: STREET 1: 126 ROSSMORE DRIVE CITY: MALVERN STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BioSig Technologies, Inc. CENTRAL INDEX KEY: 0001530766 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 264333375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 54 WILTON ROAD, 2ND FLOOR CITY: WESTPORT STATE: CT ZIP: 06880 BUSINESS PHONE: (203) 409-5444 MAIL ADDRESS: STREET 1: 54 WILTON ROAD, 2ND FLOOR CITY: WESTPORT STATE: CT ZIP: 06880 4 1 ownership.xml X0306 4 2021-02-05 0 0001530766 BioSig Technologies, Inc. BSGM 0001226425 ODONNELL JEFFREY F C/O BIOSIG TECHNOLOGIES, INC. 54 WILTON ROAD, 2ND FLOOR WESTPORT CT 06880 1 0 0 0 Common Stock 2021-02-05 4 S 0 62238 5.0013 D 194391 D Common Stock 2021-02-08 4 S 0 42762 5.1237 D 151629 D Represents the weighted average price of shares sold in multiple transactions at prices ranging from $5.00 to $5.04, inclusive. The reporting person undertakes to provide to BioSig Technologies, Inc., any security holder of BioSig Technologies, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. Represents the weighted average price of shares sold in multiple transactions at prices ranging from $5.01 to $5.21, inclusive. The reporting person undertakes to provide to BioSig Technologies, Inc., any security holder of BioSig Technologies, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. /s/ Kenneth L. Londoner, attorney-in-fact 2021-02-09